Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted ...

Funded by a $230,979 grant, an Ohio University study tests metformin to prevent Clostridioides difficile in heart patients.

Clostridium difficile, a bacterium that causes swelling of the colon and potentially deadly bouts of diarrhea, infects almost half a million people each year and contributes to the deaths of 29,000, ...

Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in patients ...

Of more than 100,000 suspected adverse drug reaction reports registered in EudraVigilance, most related to C difficile were associated with ciprofloxacin, ceftriaxone ...

High-dose cohort confirms the favorable safety profile and the dose-dependent immune response against Clostridioides ...

A new study from the University of Minnesota Medical School has demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with ...

Clostridioides difficile (C. difficile or C. diff) is a type of bacteria that causes a range of gastrointestinal symptoms, from mild diarrhoea to life-threatening colitis. It affects the colon, which ...

Clostridium difficile (C. difficile) is a common bacterial gastrointestinal infection, causing almost half a million cases of illness in the United States each year. Recovery from a C. difficile ...

Data suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer. The findings were published June 9 in ...

Sometimes scientists look for new species in the jungle or deep in the oceans. Other times they look in hospital rooms. Researchers reported this week in Nature Genetics that a subset of Clostridium ...